tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Paul Choi, 34 are a SELL (18.68%), 64 are a HOLD (35.16%), 84 are a BUY (46.15%).
Analyst Paul Choi, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 57.78% that have a potential upside of 32.7% achieved within 135 days.
Paul Choi’s has documented 400 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Pharmaceuticals sectors.
Most recent stock forecast was given on DVAX, Dynavax Technologies at 11-Feb-2025.
Analyst best performing recommendations are on SBTX (SILVERBACK THERAPEUTICS ).
The best stock recommendation documented was for VIR (VIR BIOTECHNOLOGY) at 3/1/2021. The price target of $61 was fulfilled within 1 day with a profit of $5.73 (8.59%) receiving and performance score of 85.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$3
$1.79 (147.93%)
$3
7 months ago
(26-Sep-2024)
0/4 (0%)
$2.42 (417.24%)
Hold
$7
10 months 6 days ago
(20-Jun-2024)
1/3 (33.33%)
$0.45 (6.87%)
57
Sell
$1
$-0.21 (-17.36%)
$1.5
1 years 3 months 9 days ago
(17-Jan-2024)
6/6 (100%)
$-0.02 (-1.96%)
278
Buy
1 years 4 months 8 days ago
(18-Dec-2023)
1/1 (100%)
$32.69 (83.16%)
358
Buy
$9
$7.79 (643.80%)
1 years 11 months 15 days ago
(11-May-2023)
2/4 (50%)
$4.84 (116.35%)
178
Which stock is Paul Choi is most bullish on?
Which stock is Paul Choi is most reserved on?
What Year was the first public recommendation made by Paul Choi?
